EXPERIMENTAL CELL RESEARCH

Scope & Guideline

Connecting Researchers with Groundbreaking Discoveries

Introduction

Welcome to the EXPERIMENTAL CELL RESEARCH information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of EXPERIMENTAL CELL RESEARCH, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageMulti-Language
ISSN0014-4827
PublisherELSEVIER INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1950 to 2024
AbbreviationEXP CELL RES / Exp. Cell Res.
Frequency20 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495

Aims and Scopes

EXPERIMENTAL CELL RESEARCH focuses on the intricate mechanisms governing cellular behavior, particularly in the context of disease. The journal aims to disseminate significant findings in cell biology, with a special emphasis on molecular mechanisms, cellular interactions, and the implications of these processes in health and disease.
  1. Cellular Mechanisms and Signaling Pathways:
    The journal extensively covers research on cellular signaling pathways, including those involved in proliferation, differentiation, and apoptosis. This research often employs molecular biology techniques such as RNA sequencing, proteomics, and various imaging methods.
  2. Cancer Biology and Therapeutics:
    A significant portion of the journal's publications focuses on the molecular underpinnings of cancer, including tumor microenvironment interactions, cancer stem cells, and mechanisms of drug resistance. Studies often explore therapeutic targets and novel treatment strategies.
  3. Stem Cell Research and Regenerative Medicine:
    The journal features research on stem cells, including their differentiation, therapeutic applications, and roles in tissue regeneration. This area includes investigations into mesenchymal stem cells and induced pluripotent stem cells.
  4. Cellular Stress Responses and Aging:
    Research on how cells respond to stressors, such as hypoxia and oxidative stress, is prevalent. The journal discusses cellular aging mechanisms and their implications for diseases, particularly age-related disorders.
  5. Extracellular Vesicles and Intercellular Communication:
    Studies focusing on the role of extracellular vesicles in cell communication, their role in disease progression, and therapeutic potentials are increasingly prominent in the journal.
  6. Immunology and Inflammation:
    Research related to immune cell interactions, inflammatory responses, and their implications in various diseases, including cancer and autoimmune disorders, is a core area of interest.
The journal has shown a dynamic evolution in its focus areas, with several emerging themes gaining traction in recent publications. These trends reflect the ongoing advancements in cellular research and the increasing complexity of biological systems being studied.
  1. MicroRNA and RNA Modifications:
    Research on the roles of microRNAs and RNA modifications, particularly N6-methyladenosine (m6A) modifications, in regulating gene expression and cellular functions is rapidly expanding, highlighting their significance in various diseases.
  2. Cellular Metabolism and Cancer:
    An increasing number of studies are exploring the relationship between cellular metabolism alterations and cancer progression, particularly focusing on metabolic pathways that confer advantages to cancer cells.
  3. Immunotherapy and Cancer Immunology:
    The journal is increasingly publishing research on immunotherapeutic approaches, including the role of immune checkpoints, tumor microenvironment interactions, and the modulation of immune responses in cancer.
  4. Organoid and 3D Culture Technologies:
    There is a growing trend towards using organoid and 3D culture systems to study cellular behavior in a more physiologically relevant context, which enhances the understanding of tissue development and disease.
  5. Extracellular Matrix Dynamics:
    Research on the role of the extracellular matrix in influencing cell behavior, particularly in cancer and tissue engineering, is gaining prominence as scientists uncover its critical role in cellular signaling and function.
  6. Cellular Senescence and Aging:
    The investigation of cellular senescence and its implications for aging and age-related diseases is becoming a significant focus, with studies exploring the mechanisms and therapeutic targets associated with senescent cells.

Declining or Waning

While EXPERIMENTAL CELL RESEARCH continues to explore a wide range of topics, some areas have seen a decline in publication frequency or emphasis over recent years, reflecting shifts in research focus within the field.
  1. Traditional Cell Culture Models:
    There is a noticeable decline in studies utilizing conventional 2D cell culture systems, as researchers increasingly recognize the limitations of these models in mimicking in vivo conditions.
  2. Basic Mechanistic Studies Without Clinical Relevance:
    Research that focuses solely on fundamental cellular mechanisms without a clear connection to clinical applications or translational potential is becoming less prevalent as journals seek to highlight studies with practical implications.
  3. Single-Cell Analysis Technologies:
    While single-cell technologies are gaining traction, there has been a relative decrease in basic single-cell analysis studies that do not contribute to understanding specific biological questions or diseases.
  4. In vitro Drug Screening Studies:
    Research centered on in vitro drug screening without subsequent validation in vivo or in clinical settings is becoming less emphasized, as there is a growing demand for studies that incorporate more complex biological systems.

Similar Journals

BIOLOGY OF THE CELL

Innovating research at the core of life sciences.
Publisher: WILEYISSN: 0248-4900Frequency: 12 issues/year

BIOLOGY OF THE CELL is a prominent academic journal published by Wiley, dedicated to advancing the field of cellular biology through the dissemination of innovative research and insights. With its ISSN (0248-4900) and E-ISSN (1768-322X), this journal has been a vital resource since its inception in 1981 and is set to continue its scholarly contributions until 2024. Positioned within the Q3 quartile in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, BIOLOGY OF THE CELL is recognized for its rigorous peer-review process and its commitment to high-quality publication in critical areas such as biochemistry, genetics, and molecular biology. Although the journal does not currently offer open access options, it remains accessible through the Wiley platform, ensuring that researchers, professionals, and students can benefit from its rich repository of knowledge. By linking fundamental cellular processes with broader medical implications, this journal serves as a critical platform for fostering dialogue and innovation in cellular research, making it an essential read for anyone engaged in the life sciences.

CELLULAR SIGNALLING

Connecting Discoveries in Molecular Biology
Publisher: ELSEVIER SCIENCE INCISSN: 0898-6568Frequency: 12 issues/year

CELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.

TRENDS IN CELL BIOLOGY

Leading the Charge in Cell Biology Discoveries
Publisher: CELL PRESSISSN: 0962-8924Frequency: 12 issues/year

TRENDS IN CELL BIOLOGY, published by CELL PRESS, is a premier journal in the field of cell biology, recognized for its high-impact contributions since its inception in 1991. As a distinguished member of the Q1 quartile within its category, the journal holds an impressive Scopus ranking of #8 out of 285, placing it in the 97th percentile of the field, which underscores its reputation for excellence. The journal serves as an essential resource for researchers, professionals, and students who are engaged with groundbreaking advancements in biochemistry, genetics, and molecular biology. Although it is not open access, it provides critical insights into the latest trends, reviews, and advancements in cell biology, making it a crucial tool for anyone committed to understanding the complexities of cellular systems. With a focus on innovative and transformative research, TRENDS IN CELL BIOLOGY continues to shape the discourse in cell biology and enhance the scientific community's knowledge.

FEBS Journal

Catalyzing Progress in Biochemistry and Beyond
Publisher: WILEYISSN: 1742-464XFrequency: 24 issues/year

FEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.

CELL RESEARCH

Pioneering Research for a Healthier Tomorrow
Publisher: SPRINGERNATUREISSN: 1001-0602Frequency: 12 issues/year

CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.

Molecular Cell

Connecting Molecular Genetics with Cellular Functionality.
Publisher: CELL PRESSISSN: 1097-2765Frequency: 24 issues/year

Molecular Cell, published by Cell Press, is a leading journal in the fields of cell biology and molecular biology. Established in 1997, this prestigious journal boasts a significant impact within the scientific community, evidenced by its impressive 2023 Scopus rankings, placing it in the top 2% of its field (Rank #10/410 in Molecular Biology, Rank #12/285 in Cell Biology). With a focus on cutting-edge research that bridges the gap between molecular genetics and cellular function, Molecular Cell serves as an essential platform for the dissemination of vital findings and innovative methodologies. Although it follows a traditional publishing model without Open Access options, its rigorous peer-review process and high standards ensure that articles published within these pages are of the utmost quality, making it an invaluable resource for researchers, professionals, and students alike seeking to stay at the forefront of scientific discovery. The journal's address is 50 Hampshire St, Floor 5, Cambridge, MA 02139, United States, reinforcing its commitment to fostering scientific excellence and collaboration.

CELL CYCLE

Leading Insights into Molecular and Developmental Biology.
Publisher: TAYLOR & FRANCIS INCISSN: 1538-4101Frequency: 24 issues/year

CELL CYCLE, an esteemed journal published by Taylor & Francis Inc., stands at the forefront of biological research, focusing on the intricate mechanisms of cell proliferation, molecular biology, and developmental biology. With an ISSN of 1538-4101 and an E-ISSN of 1551-4005, this journal has established its influence in the field with a commendable impact factor reflecting its rigorous peer-review process and high-quality publications. Notably, in 2023, it achieved a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in both Cell Biology and Developmental Biology, marking its vital role in advancing scientific understanding and innovation. Operating within a converged framework from 2002 to 2024, CELL CYCLE caters to a diverse audience of researchers, professionals, and students eager to explore contemporary findings and emerging trends. The journal's objective is to disseminate groundbreaking research that enhances our understanding of cellular mechanisms, fostering collaboration and innovation. Although not an open-access journal, it remains a premier source for those engaged in cell cycle research, and its contributions have significant implications for fields such as healthcare, biotechnology, and genetics.

Cellular and Molecular Bioengineering

Exploring Cellular Dynamics Through Molecular Insights
Publisher: SPRINGERISSN: 1865-5025Frequency: 4 issues/year

Cellular and Molecular Bioengineering, published by SPRINGER, is a prominent journal dedicated to the exploration of interdisciplinary approaches in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 1865-5025 and an E-ISSN of 1865-5033, this journal has been a pivotal resource since its inception in 2009, showcasing groundbreaking research that combines innovative modeling and simulation techniques with cellular and molecular applications. As a Q2 journal in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Modeling and Simulation categories, it ranks favorably in the Scopus metrics, placing 62nd out of 324 in Mathematics_ Modeling and Simulation, and 69th out of 221 in General Biochemistry, Genetics and Molecular Biology. The journal's commitment to quality research and its contribution to advancing academic dialogue make it essential for researchers, professionals, and students seeking to stay at the forefront of bioengineering innovation. While it currently does not offer open access, it continues to provide significant insights and empirical studies that can help shape future developments in the field, reinforcing its role as a key player in cellular and molecular bioengineering.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Advancing the Frontiers of Biochemistry and Cell Biology
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1357-2725Frequency: 12 issues/year

The International Journal of Biochemistry & Cell Biology, published by Pergamon-Elsevier Science Ltd, stands as a pivotal resource in the fields of biochemistry and cell biology. With an ISSN of 1357-2725 and an E-ISSN of 1878-5875, this prestigious journal has been a key platform for disseminating cutting-edge research since its inception in 1995. The journal currently holds an impressive Q1 ranking in Biochemistry and a Q2 ranking in Cell Biology for the year 2023, reflecting its commitment to high-quality research and its influence within the scientific community. With a significant Scopus ranking of 94/438 in Biochemistry and 96/285 in Cell Biology, the journal plays a crucial role in advancing knowledge and fostering innovative approaches in these dynamic fields. Though it is not an open-access journal, the International Journal of Biochemistry & Cell Biology remains accessible to a wide audience, making it a vital resource for researchers, professionals, and students alike, who are eager to explore and contribute to the ongoing advancements in biochemistry and cell biology.

Advances in Cancer Biology-Metastasis

Fostering Collaboration for Cancer Breakthroughs.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Advances in Cancer Biology-Metastasis is an emerging journal published by Elsevier, aimed at advancing our understanding of the complexities of cancer biology, with a specific focus on the mechanisms and pathways related to metastasis. With an E-ISSN of 2667-3940, this journal offers a platform for researchers, professionals, and students in the fields of Cancer Research and Cell Biology to disseminate innovative findings and discuss novel therapeutic approaches. Though currently classified in the Q4 quartile across both Cancer Research and Cell Biology categories, the journal aspires to enhance its impact through rigorous peer review and high-quality publication. Positioned to cover the years from 2021 to 2024, it seeks to bridge gaps in foundational knowledge and promote collaborative research efforts that could pivot the current understanding of cancer metastasis. Researchers are encouraged to take advantage of this platform to advocate for advancements in cancer biology, making significant contributions that can influence both academic and clinical practices.